Finally, in order to identify associations between germline CYP1B1 polymorphism and patients’ survival, a clinical study was done, including in advanced HNSCC patients treated with chemotherapy and cetuximab. Here, CYP1B1 is linked to head and neck squamous cell carcinoma.